Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T cell-mediated immune responses?

Transplantation
C P LarsenT C Pearson

Abstract

Fas/Fas ligand interactions serve as a signaling pathway for apoptosis (1-3), an important regulatory mechanism in the development and function of the immune system (4-9). Recent evidence that Fas-dependent apoptosis is also an important mode of T cell cytotoxicity (10-13) suggested that Fas might play a critical role in the effector phase of T-dependent immune responses, such as allograft rejection. We observed that Fas transcripts are constitutively expressed in syngeneic and allogeneic murine cardiac transplants, while Fas ligand (FasL) is up-regulated only in rejecting allografts. Surprisingly, the absence of an intact Fas/FasL pathway did not alter the tempo of allograft rejection, even CD4-dependent rejection. These results indicate that Fas/FasL interactions are not essential mediators of T cell-induced allograft damage. Rather, as suggested in other studies, the Fas pathway may be principally involved in the regulation of clonal expansion and subsequent contraction of T cell populations during immune responses.

Citations

Feb 5, 1999·European Journal of Immunology·M WiseH Waldmann
Feb 1, 1997·Transplantation Proceedings·K Yagyu, P J van Breda Vriesman
Dec 5, 1998·Transplantation Proceedings·K WatanabeA Kakita
Apr 15, 1997·Human Immunology·G Berke
Jul 19, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Chul Woo YangWilliam M Bennett
May 11, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Adam S BartlettStephen R Munn
Jan 27, 1997·Transplantation·S D BergeseC G Orosz
Apr 27, 1997·Transplantation·M J SmythJ A Trapani
Nov 14, 1997·Transplantation·J G BoonstraM R Daha
May 16, 1998·Transplantation·D Kabelitz
Mar 22, 2001·Transplantation·J TrambleyC P Larsen
Feb 8, 2000·Liver·A Benedetti, L Marucci
Nov 28, 2007·Annual Review of Pathology·Lynn D CornellRobert B Colvin
Apr 13, 2005·Nephron. Clinical Practice·Gyu-Tae ShinHeungsoo Kim
Dec 20, 1999·Japanese Circulation Journal·Y FurukawaS Sasayama
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·J StrehlauT B Strom
Mar 1, 1996·Transplant Immunology·D Z AlexanderC P Larsen
Feb 15, 2000·International Reviews of Immunology·O M Martinez, S M Krams
Oct 3, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D KayserP F Halloran
Jan 15, 2002·Cardiology Clinics·L W MillerB M McManus
Jan 9, 2004·Pediatric Clinics of North America·Biagio A Pietra
Jul 1, 1998·The Annals of Thoracic Surgery·Y KageyamaY Harada
Jun 8, 1999·The Journal of Surgical Research·S HiroyasuY Muto
Apr 1, 1998·Transplantation·S M KramsO M Martinez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis